Pfizer weighs working with BioNTech on potential coronavirus vaccine: R&D head

Pfizer Inc is considering a collaboration with German drugmaker BioNTech SE to develop vaccines for the coronavirus using BioNTech’s mRNA-based drug development platform, Pfizer’s R&D head told Reuters on Thursday.